You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 3, March 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Presidential Address
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Evolving Role of Combined Modality Therapy in Head and Neck Cancer

Arch Otolaryngol Head Neck Surg. 2000;126:265-269.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It is a privilege and an honor to address the members of the American Head and Neck Society and our guests. To my knowledge, this organization represents the largest group of individuals in the world whose primary mission is dedicated to promoting education and research on head and neck cancer. This past year, an inaugural year, has been a major step forward for head and neck surgeons in this country. We have restructured; we have accommodated important goals from each of the 2 merging societies; and, most importantly, we have been able to work together to build an infrastructure that will serve us well for the future. I am indebted to my copresident, Ashok Shaha, with whom it has been an absolute pleasure to interact. He is a man who is sensitive to those around him, as well as a great team player. I would also like to acknowledge the . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

RADPLAT: An Alternative to Surgery?
Alkureishi et al.
The Oncologist 2006;11:469-480.
ABSTRACT | FULL TEXT  

Effectiveness of Superselective and Selective Neck Dissection for Advanced Nodal Metastases After Chemoradiation
Robbins et al.
Arch Otolaryngol Head Neck Surg 2005;131:965-969.
ABSTRACT | FULL TEXT  

Intra-Arterial High-Dose Chemotherapy with Cisplatin as Part of a Palliative Treatment Concept in Oral Cancer
Rohde et al.
Am. J. Neuroradiol. 2005;26:1804-1809.
ABSTRACT | FULL TEXT  

The Synergistic Cytotoxicity of Cisplatin and Taxol in Killing Oral Squamous Cell Carcinoma
Huang et al.
Jpn J Clin Oncol 2004;34:499-504.
ABSTRACT | FULL TEXT  

Quality-of-Life Assessment After Supradose Selective Intra-arterial Cisplatin and Concomitant Radiation (RADPLAT) for Inoperable Stage IV Head and Neck Squamous Cell Carcinoma
Ackerstaff et al.
Arch Otolaryngol Head Neck Surg 2002;128:1185-1190.
ABSTRACT | FULL TEXT  

Concomitant Chemoradiotherapy in Pyriform Sinus Carcinoma
Prades et al.
Arch Otolaryngol Head Neck Surg 2002;128:384-388.
ABSTRACT | FULL TEXT  

Analysis of Risk Factors Predictive of Distant Failure After Targeted Chemoradiation for Advanced Head and Neck Cancer
Doweck et al.
Arch Otolaryngol Head Neck Surg 2001;127:1315-1318.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.